Setting new standards in information exchange for the pharmaceutical and biotech industry
Is Your CMO’s Role Evolving Fast Enough?
October 30, 2015
The role of the Chief Medical Officer at pharmaceutical companies is evolving to improve patient care and outcomes.
The position of Chief Medical Officer (CMO) is evolving as both the public and the broader medical community look for pharmaceutical companies to apply more ethical and scientific rigor to decision making. Some pharmaceutical companies are investing in a single, global top-level executive who is both credibly independent and capable of meeting two primary objectives: making the voice of the patient heard at the highest levels of the organization and representing the company externally as its primary medical representative.
Read more from the Mckinsey Report here: http://www.mckinsey.com/insights/health_systems_and_services/is_your_cmos_role_evolving_fast_enough